Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
Karrison
T G
TG
Vogelzang
N J
NJ
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D015552:Injections, Intralesional; D007376:Interleukin-2 / Q000008:administration & dosage*; D008654:Mesothelioma / Q000188:drug therapy*; D010997:Pleural Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D007376:Interleukin-2